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Case Presentation:
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Figure 2: H&E Punch biopsy showing
varying degrees of patchy epidermal
necrosis.
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Figure 3: H&E Punch biopsy showing
vascular thrombi identified within the
papillary dermal capillary vessels and
small arterioles of the mid-dermis.

Patient: D.F. is a 52 y.o. Caucasian male.
History of Present Illness: Patient presented to the emergency department with
skin mottling of the lower extremities, burning, and numbness of the feet, all of which were
present for several days.  The skin lesions were preceded by sudden onset of headache, chills,
abdominal pain, and bloody diarrhea.  Within 24 hours of the hospital admission, the patient
developed neurologic changes and required intubation.  Dermatology was consulted to identify
a causal process for the skin lesions.
Medical History: Hypertension, hyperlipidemia
Family History: None
Medications/Interventions: Fresh frozen plasma, plasma exchange, metronidazole,
ciprofloxacin, piperacillin/tazobactam
Physical Examination: Mottled purple dusky papules and patches in a reticulated pattern
on the face, chest, abdomen, arms, and legs.  Blistering and ulceration is present on the
dependent areas; primarily the legs and feet.
Laboratory Data: CBC: Hgb 17.7 (wnl), Hct 42.7 (wnl), + schistocytes, WBC 21.0 (4.5-11
thou/cm2), platelets 19 (150-400 thou/cm2), INR 2.5 (≤ 1.0), PTT 45.6 (21.6-35.6), D-dimer>20
(<0.50 ug/ml), fibrinogen 237 (wnl), BUN 55 (10-26 mg/dl), creatinine 4.2 (0.7-1.5 mg/dl), AST
260 (7-40 U/L), ALT 179 (7-40 U/L), LDH 1767 (<190), blood culture positive for Capnocytophaga
species.
Studies: CT of the abdomen/pelvis showed no contrast in the ureters on delayed images.
Biopsy:
Health Network Laboratories (S11-8503, 04/02/2011) Left medial and lateral knee: “Subtle and
relatively rare scattered vascular thrombi identified within the papillary dermal capillary vessels
and small arterioles of the mid-dermis.  There are also varying degrees of associated overlying
patchy epidermal necrosis identified.  There is no evidence of vasculitis, cholesterol emboli, or
calcification of small vessels noted.”
Reason for Presentation: Interest

Discussion:

Figure 1: Purple dusky papules
and patches, with blistering and
ulceration, in a livedoid pattern on
the lower extremities.

20x
Figure 4: H&E Punch biopsy showing
no evidence of vasculitis, cholesterol
emboli, or calcification of small
vessels.

Thrombotic Thrombocytopenic Purpura (TTP) is a vaso-occlusive process, and has been described
as a cause of livedoid vasculopathy.  The acronym PURPLE (painful purpuric ulcers with reticular
pattern of the lower extremities) has been used to describe characteristic skin lesions.  The lesions
are primarily seen first in dependent areas, but may be diffuse.  Reduction in blood flow can be a
gradual process and culminate in complete occlusion of the arteriole.  Hemorrhagic infarcts follow the
occlusion and extensive areas of necrosis and ulceration follow, which ultimately many progress to
gangrene.

Classically, a pentad of symptoms was proposed for TTP: thrombocytopenia,
microangiopathic hemolytic anemia, neurological symptoms, renal dysfunction,
and fever.  Since the advent of therapeutic plasma exchange in the 1970’s, survival
was seen to increase to 78%.  With this significant decrease in mortality, diagnostic
criteria became less stringent, and are now classified as only microangiopathic
hemolytic anemia and thrombocytopenia with no apparent alternative etiology.  The
reclassification of criteria for TTP resulted in an eightfold increase in the number of
patients treated early with plasma exchange.
The ultimate cause of TTP is unknown.  However, in recent years a deficiency of von
Willebrand factor-cleaving protease, termed “ADAMTS 13” (acronym for a disintegrin
and metalloprotease with thrombospondin-1-like domains) has been identified.  
The function of ADAMTS 13 is to cleave large von Willebrand factor multimers that
are synthesized and secreted by endothelial cells.  When ADAMTS 13 is absent,
the large von Willebrand factor multimers in plasma can react with platelets, and
cause the aggregation of platelet thrombi that is characteristic of TTP.  The value
of measurements of ADAMTS 13 activity and inhibitors remains unclear due to
discrepancies among assay techniques and correlation with in vivo activity, but may be
of value in predicting risk of recurrence.  
Early diagnosis and treatment of TTP is essential in the survival of affected
patients.  Our patient continued to exhibit microangiopathic hemolytic anemia and
thrombocytopenia with no apparent alternative etiology, after adequate intervention for
disseminated intravascular coagulation (DIC) caused by a gram negative blood stream
infection.  Biopsy was helpful in determining a vaso-occlusive process early, and
identified the need to initiate plasma exchange.  In the setting of a dropping platelet
count with normalization of the coagulation panel, TTP should be suspected, even
in the setting of overlapping DIC.  Although our patient ultimately required bilateral
chopart amputations of his lower extremities, his renal function was preserved and he
has recovered.  
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